Back to top

Research Daily

Monday, July 25, 2016

Today's must-read reports are for Intel (INTC), Biogen (BIIB) and AT&T (T).

Intel shares have moved to Zacks Rank # 2 (Buy) following the company's Q2 results where it's June-quarter numbers weren't that impressive, but the outlook for the curent and following quarters was favorable. The positive momentum in the stock and EPS estimates reflects this positive guidance. In the updated research report issued today, our analyst discusses the positive outlook for Intel's data center business. Intel’s leading position in PCs, strength in servers, growing position in software and IoT segments and headway in process technology are all positive indicators of its future growth. (You can read the full research report on INTC here.)

Biogen’s Q2 results were impressive with earnings beating estimates by a huge margin & the company raising its outlook. The analyst likes Biogen’s strong position in the multiple sclerosis market where it has a wide range of products. Cost cutting efforts and MS franchise sales should help Biogen achieve its guidance. In addition to consolidating its position in this market, Biogen is also working on diversifying its pipeline. (You can read the full research report on BIIB here.)

AT&T's June quarter results didn't impress, but the company remains on track for achieving $1.5 billion in synergies from the DIRECTV purchase this year and $2.5 billion in 2017. These synergies, coupled with effective cost controls and steady business are driving AT&T's attractive free cash flow outlook, which is on track to total $16 billion this year. The analyst likes the combination of U-verse, DIRECTV’s satellite TV and GigaPower Internet service which can now provide traditional cable TV as well as mobile video streaming services. (You can read the full research report on T here.)

Other noteworthy reports we are featuring today include Stryker (SYK), Roche (RHHBY) and Rogers Communications (RCI).

The 15 research reports featured in today's Research Daily are a small part of the roughly 100 reports issued by our analyst team today. You can find all of today's stock research reports here.

Sheraz Mian

Director of Research

Note: Sheraz Mian regularly provides earnings analysis on Zacks.com and appears frequently in the print and electronic media. His weekly earnings related articles include Earnings Trends and Earnings Preview. He also provides weekly commentary to Zacks Premium subscribers and manages the Zacks Focus List and Top 10 portfolios. If you want an email notification each time Sheraz publishes a new article, please click here.

Featured Reports

New Upgrades

New Downgrades